MSB 2.03% $1.45 mesoblast limited

Will the FDA refuse approval in the face of the favourable ODAC 9 versus 1 vote?, page-25

  1. 288 Posts.
    lightbulb Created with Sketch. 170
    My feeling exactly. The FDA review materials were not just appropriately rigorous and putting us through our paces, their tone bordered on the contemptuous.
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.